Brief: Cipla Launches Yurpeak For Obesity And Type 2 Diabetes
10/12/2025 11:42
Dec 10 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - LAUNCHES YURPEAK FOR OBESITY AND TYPE 2 DIABETES CIPLA - TO DISTRIBUTE YURPEAK IN INDIA AFTER DCGI APPROVAL Source text: ID:nBSE2SmsNV Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated